Product focus
Metabolic, appetite, weight-management, or body-composition support.
THECARE / PRODUCT PROTOCOL
Single ingredientRetatrutideSelect your vial strength
Your guide to preparation, dosing & use.
Vial strength15 mg per vial
After preparation15 mg / 1.5 ml
AdministrationSubcutaneous (SQ)
Which vial do you have?
Choose the mg amount printed on your vial. Your guide will appear after you select it.
01
PRODUCT INFORMATION
Benefits
Formulation
Retatrutide
Who it is intended for
Clients pursuing medically supervised weight-management or metabolic support.
02
WHAT TO WATCH FOR
Side Effects
Nausea, vomiting, diarrhea, constipation, bloating, and injection site irritation.
When to pause and get help
Pause use and get help for red flag symptoms, unexpected side effects, dose errors, missed doses with symptoms, pregnancy, new diagnosis, new medication, or uncertainty about storage/reconstitution.
03
WHEN TO GET HELP
Adverse Effects
URGENT SYMPTOMS
Get urgent medical help.
Severe allergic reaction, trouble breathing, chest pain, fainting, severe abdominal pain, persistent vomiting, severe swelling, infection signs, or rapidly worsening symptoms require urgent medical help.
Who needs a safety review?
Before using this product
Pregnant/breastfeeding clients, minors, clients with active infection, uncontrolled medical conditions, severe allergies, or complex medication histories should complete safety review before use. GLP-1 products also need review for pancreatitis history, gallbladder disease, gastroparesis, thyroid cancer/MEN2 history, diabetes medications, and severe GI disease.
Conditions and medicines to review
Pregnant/breastfeeding clients, minors, clients with active infection, uncontrolled medical conditions, severe allergies, or complex medication histories should complete safety review before use. GLP-1 products also need review for pancreatitis history, gallbladder disease, gastroparesis, thyroid cancer/MEN2 history, diabetes medications, and severe GI disease. Disclose all prescriptions, OTC medications, supplements, allergies, and prior reactions.
04
MEASURE CORRECTLY
Dosing Guide
YOUR DOSE · FOLLOW YOUR PRESCRIPTION
10 units SQ once weekly. Follow your prescribed dose.
Units refer to U-100 syringe markings.
By volume, this vial contains 15 measurements at the starting dose. Supply varies when your dose changes. Follow your prescribed course and the discard date on your vial.
Dose changes
Continue your prescribed dose. If appetite returns after 2–3 weeks at the same dose, contact your care team to review your response. Confirm your next dose, start date, and individual dose limit before increasing.
U-100 syringe conversion
For Retatrutide 15 mg in 1.5 mL after preparation.
| Syringe mark U-100 | Volume mL | Retatrutide mg |
|---|---|---|
| 1 | 0.01 | 0.1 |
| 5 | 0.05 | 0.5 |
| 10 | 0.10 | 1 |
| 20 | 0.20 | 2 |
| 25 | 0.25 | 2.5 |
| 50 | 0.50 | 5 |
1 U-100 marking = 0.01 mL. Multiply the amount per vial by the mL drawn, then divide by the final mL in the vial. Amounts are rounded for display; match the vial label and written order.
Preparation & storage
Mixing instructions
Add 1.5 ml BAC water to the vial. Inject it slowly down the inside wall of the vial, then gently swirl until dissolved; do not shake. Use sterile technique.
Package contents
Product vial.
Supplies
Confirm syringes, needles, alcohol pads, BAC water, and disposal supplies are included or available before starting.
Before mixing / opening
Store at the temperature on your product label. Protect from light and follow the expiry date.
After mixing
Write the mixing date on your vial. Follow its storage temperature and discard date. Discard any remaining solution on that date.
If the package arrives warm
Do not use if package integrity is questionable. Contact support for review and keep product per storage instructions while awaiting guidance.
05
USE & FOLLOW-UP
Protocol
Route
Self-injection: SQ (subcutaneous)
Injection site
Self-injection: SQ (subcutaneous). Use fatty tissue such as the abdomen, outer thigh, or back of upper arm; rotate sites each dose and avoid irritated, bruised, scarred, or damaged skin. For abdomen, stay at least 2 inches from the navel.
Subcutaneous injection: choose a site
Abdomen
Choose fatty tissue at least 2 inches (5 cm) from the navel.
Side of abdomen
Choose healthy fatty tissue below the ribs and above the hip bone.
Back of upper arm
A trained helper can use the fatty tissue on the back of the upper arm.
Outer thigh
Choose fatty tissue on the outer middle thigh, away from the knee and hip.
45° and 90° examples
These illustrations identify tissue layers and example angles; they are not to scale. Needle length, angle and whether to lift a fold depend on the prescribed device and your training; stop and ask the clinic if either is unspecified.
Check the order and equipment
Match name, vial strength, final concentration, SQ route, expiration and discard date to your prescription. Use the prescribed U-100 syringe only if the order specifies it; its marks measure volume.
Prepare and measure
Wash and dry hands. Use a clean surface, a new sterile needle and syringe, and an alcohol pad. Check solution appearance, clean the stopper and let it dry. Draw only the prescribed volume and recheck the mark and bubbles.
Choose and clean a site
Choose one healthy site shown above and rotate each time. Avoid red, hard, bruised, scarred or tender skin. Clean the spot and let it dry. Do not touch it again.
Inject into fatty tissue
Gently lift a skin-and-fat fold if your training calls for it. Use the 45° or 90° angle specified for your needle and body habitus. Insert into fat, press the plunger steadily, then withdraw at the same angle.
Finish and dispose
Press clean gauze if needed; do not rub. Do not recap or reuse the needle. Put needle and syringe immediately in a sharps container; close it at about three-quarters full and use local disposal rules.
Refills and switching
When to reorder
Request a refill before you run out or reach your vial’s discard date.
Before a refill
Current dose, frequency, response, side effects, weight/goal changes if relevant, missed doses, remaining supply, and any new medications or medical changes.
Before switching
Previous product name, dose, last injection date, side effects, response, reason for switching, current medications, and confirmation that switching is appropriate.
EXTRA INFORMATION
Product documents
Supplier documents for reference.